Bottom line
FACDX vs JEHSX: the short answer
FACDX (Fidelity Advisor Health Care Fund) and JEHSX (Health Sciences Trust) share a meaningful slice of their top holdings — about 47% by weight.
FACDX is cheaper at 0.96% vs 1.04% — a difference of $8.00 a year per $10,000 invested.
Over five years, JEHSX returned +4.2% a year vs +2.3% for FACDX (reporting dates differ).
Updated Nov 19, 2026
FACDX vs JEHSX side by side
| FACDX | JEHSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Fidelity | John Hancock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.96% | 1.04% |
| Annual cost per $10k | $96 | $104 |
| 10-yr cost on $10k (prospectus) | $1,685 | $1,282 |
| Max front load | — | — |
| 12b-1 fee | 0.25% | 0.05% |
| 1-yr return | +7.7% | +19.5% |
| 5-yr return (annualized) | +2.3% | +4.2% |
| 10-yr return (annualized) | +7.6% | +8.7% |
| Best quarter | +21.3% | +23.6% |
| Worst quarter | −15.0% | −16.1% |
| Net assets (fund) | $3.1B | $251.3M |
| Number of holdings | 154 | 173 |
| Portfolio turnover | 74% | 68% |
| Returns as of | Sep 30, 2026 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FACDX | JEHSX | Difference |
|---|---|---|---|
| 2025 | +14.2% | +19.5% | −5.2% |
| 2024 | +3.9% | +1.8% | +2.1% |
| 2023 | +3.8% | +4.3% | −0.4% |
| 2022 | −13.1% | −13.1% | +0.0% |
| 2021 | +11.2% | +11.2% | 0.0% |
| 2020 | +21.1% | +27.2% | −6.1% |
| 2019 | +27.9% | +28.7% | −0.8% |
| 2018 | +7.3% | +0.7% | +6.7% |
| 2017 | +24.1% | +27.5% | −3.4% |
| 2016 | −10.3% | −10.6% | +0.2% |
Source: Fund prospectus bar charts
Holdings overlap
11 of FACDX's top 25 holdings also appear in JEHSX's top 25.
| Holding | FACDX | JEHSX |
|---|---|---|
| ELI LILLY and CO | 7.66% | 14.30% |
| Danaher Corp | 6.75% | 1.51% |
| Thermo Fisher Scientific Inc | 6.31% | 2.67% |
| Unitedhealth Group Inc | 4.17% | 5.95% |
| JOHNSON and JOHNSON | 3.78% | 6.33% |
| Abbvie Inc | 3.62% | 5.28% |
| MERCK and CO INC | 2.09% | 4.21% |
| Natera Inc | 1.65% | 1.49% |
| Guardant Health Inc | 1.48% | 1.28% |
| Cvs Health Corp | 1.29% | 0.98% |
| Gilead Sciences Inc | 1.25% | 2.95% |
Source: SEC Form N-PORT
FACDX top 10
- ELI LILLY and CO — 7.66%
- Danaher Corp — 6.75%
- Thermo Fisher Scientific Inc — 6.31%
- Unitedhealth Group Inc — 4.17%
- JOHNSON and JOHNSON — 3.78%
- Abbvie Inc — 3.62%
- Fidelity Revere Street Trust — 2.54%
- Argenx Se — 2.09%
- MERCK and CO INC — 2.09%
- West Pharmaceutical Svcs Inc — 2.06%
JEHSX top 10
- Eli Lilly and Company — 14.30%
- Johnson and Johnson — 6.33%
- UnitedHealth Group Incorporated — 5.95%
- AbbVie Inc. — 5.28%
- Merck and Co. Inc. — 4.21%
- Gilead Sciences Inc. — 2.95%
- Thermo Fisher Scientific Inc. — 2.67%
- Vertex Pharmaceuticals Incorporated — 2.38%
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
FAQ
What is the difference between FACDX and JEHSX?
Which is cheaper, FACDX or JEHSX?
Should I own both FACDX and JEHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.